Blenkiron et al. 35 showed that elevated miR-21 was associated with ER-positive tumours, and Huang et al. 36 reported that miR-21 was up-regulated via the MAP (ERK1/2) pathway upon stimulation of HER2 signalling in BC cells. This evidence concerns the gene MAPK3 and breast cancer.